Trasylol Lawsuit & Claim Information Attorney

Fill out the Trasylol Intake Form

Trasylol (Also known under the name of Aprotinin) is a drug used to reduce blood loss and the need for blood transfusion in patients undergoing heart surgeries like cardiopulmonary bypass (CPB) and coronary artery bypass graft surgery (CABG).Recently studies have linked Trasylol to an increased risk of kidney damage, heart attacks, and strokes. While these studies are preliminary, there exists a very real possibility that the Trasylol manufacturer, Bayer, will become involved in extensive litigation around this product. In fact, some lawsuits have already been filed. The link in this website to the 60 minutes segment and FDA information more fully describes the dangers and information currently known regarding this drug.

If you or a person you are close to experienced complications after cardiopulmonary bypass (CPB) or coronary artery bypass graft surgery (CABG) you should immediately contact your medical providers to determine if Trasylol was used during the procedure. If Trasylol was used and you or a loved experienced complications you may be entitled to compensation. To learn more about your legal rights or to inquire about an Trasylol class action lawsuit or individual lawsuit please immediately submit your information in the box above to receive a free case evaluation.

The United States Food and Drug Administration (FDA) issued a Trasylol public health advisory regarding Trasylol on February 8, 2006. The advisory stated the FDA is assessing study data and conducting a safety evaluation for the drug Trasylol to assess the drug's risks.

The FDA warned Doctors to carefully weigh the potential benefits and risks of Trasylol before administering the drug to patients. More information regarding what Trasylol manufacturer Bayer knew and when they knew it is available on the Trasylol Information Timeline page. Patients who take Trasylol should be monitored for toxicity to the kidneys, heart, and central nervous system. Adverse events regarding Trasylol must be promptly reported to Bayer or the FDA Medwatch program to further their study of this drug.

Patients or Patients' loved ones who took Trasylol and have suffered complications such as stroke, heart attack, kidney failure, or death should contact our law firm for a free case consultation, and may do so on the red submission box above. We are investigating cases nationwide.

Additional Trasylol Information

• FDA Press Conference on Trasylol I
• FDA Press Conference on Trasylol II
• FDA Trasylol Public Health Advisory
• Trasylol 60 Minutes Report
• Trasylol FAQ
• Trasylol FDA Marketing Suspension
• Trasylol Information Timeline